Whalesbook
### International Capital Ambitions Amplify
Capri Global Capital Ltd. has significantly amplified its international capital market ambitions by authorizing a substantial $1 billion Global Medium Term Note (GMTN) program. This initiative, formalized on March 25, 2026, by the company's Management Committee, builds upon prior board approval from January 29, 2026. The program allows for the issuance of foreign currency bonds, notes, and other debt securities under U.S. regulations (Regulation S and/or Rule 144A). Crucially, these securities will be exclusively offered to international investors, with no sales permitted within India. This aggressive expansion into offshore debt markets marks a considerable escalation from earlier plans, such as a potential $300 million maiden dollar bond discussed in February 2026.
### The NBFC Funding Landscape Shifts
Capri Global's move aligns with a broader trend among Indian non-banking financial companies (NBFCs) increasingly seeking funds internationally. A domestic credit squeeze and potentially more favorable borrowing costs abroad are driving this shift. In 2025, Indian NBFCs secured $3.67 billion in overseas syndicated loans, more than doubling the previous year's total. Notably, lower-rated NBFCs have found significant access to these markets. Sector peers have demonstrated the cost advantage, with Muthoot Finance raising dollar-denominated bonds at a lower coupon rate compared to domestic issuances. The recent sovereign rating upgrade for India to 'BBB' and softening US interest rates further enhance the attractiveness of offshore borrowing. However, these advantages are tempered by risks such as exchange-rate volatility and credit concerns for some issuers.
### Valuation and Investor Sentiment Under Scrutiny
The company's stock, trading around ₹167.50 as of March 25, 2026, saw a marginal decline of 0.39% on the day of the GMTN announcement, suggesting an immediate cautious investor reaction to the enlarged funding plan. Capri Global Capital currently holds a market capitalization in the range of ₹16,328 crore to ₹16,549 crore, with a trailing P/E ratio between 18.86x and 23.34x. While these valuation metrics reflect growth expectations, they appear higher than some direct peers like Repco Home Finance (P/E 5.4x) and Satin Creditcare Network (P/E 12.8x), indicating a potential valuation premium. Analyst sentiment is divided; while the consensus among ten analysts points to a 'Buy' rating with an average 12-month target price of ₹234.6, signaling optimism, some reports suggest rich valuations or even 'Reduce' ratings from specific institutions.
### The Bear Case: Leverage and Execution Risks
The substantial $1 billion GMTN authorization introduces increased leverage risk for Capri Global. While intended to fuel growth, this significant debt issuance requires careful management to avoid undue financial strain. The company's reported low interest coverage ratio is a point of concern in this context. The execution of the GMTN program itself, while following established regulatory frameworks, carries inherent risks related to market timing, pricing, and the ability to draw down funds effectively. Furthermore, the company's net profit growth has seen significant fluctuations historically, and its P/E ratio has seen substantial swings, peaking at 68.7x in March 2024. The muted stock reaction on the announcement day could signal investor apprehension about the sheer scale of offshore borrowing and its implications for the company's financial structure moving forward.
### Future Outlook and Growth Drivers
Capri Global Capital has articulated ambitious growth targets, aiming for an Assets Under Management (AUM) of ₹50,000-55,000 crore by FY28. Key growth drivers identified include its gold loan business, which offers high yields, expanding co-lending services, and insurance distribution through its digital ecosystem. The company is also strategically expanding into South India to diversify its geographical footprint. The GMTN program, alongside recent domestic debt issuances and equity infusions, forms part of a comprehensive strategy to ensure robust funding for these expansion plans. Analysts anticipate sustained AUM growth and potential margin support from a favorable product mix and fee income scale-up.